Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder caused by an increase in amyloid metabolism. The calcium hypothesis of AD explores how activation of the amyloidogenic pathway may function to remodel the neuronal Ca2+ signaling pathways responsible for cognition. Hydrolysis of the β-amyloid precursor protein (APP) yields two products that can influence Ca2+ signaling. Firstly, the amyloids released to the outside form oligomers that enhance the entry of Ca2+ that is pumped into the endoplasmic reticulum (ER). An increase in the luminal level of Ca2+ within the ER enhances the sensitivity of the ryanodine receptors (RYRs) to increase the amount of Ca2+ being released from the internal stores. Secondly, the APP intracellular domain may alter the expression of key signaling components such as the RYR. It is proposed that this remodeling of Ca2+ signaling will result in the learning and memory deficits that occur early during the onset of AD. In particular, the Ca2+ signaling remodeling may erase newly acquired memories by enhancing the mechanism of long-term depression that depends on activation of the Ca2+-dependent protein phosphatase calcineurin. The alteration in Ca2+ signaling will also contribute to the neurodegeneration that characterizes the later stages of dementia.
Similar content being viewed by others
References
Bezprozvanny I, Mattson MP (2008) Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci 31:454–463
Bojarski L, Herms J, Kuznicki J (2008) Calcium dysregulation in Alzheimer's disease. Neurochem Int 52:621–633
Busche MA, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold KH, Haass C, Staufenbiel M, Konnerth A, Garaschuk O (2008) Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Science 321:1686–1689
Cao X, Südhof TC (2001) A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293:115–120
Chakroborty S, Goussakov I, Miller MB, Stutzmann GE (2009) Deviant ryanodine receptor-mediated calcium release resets synaptic homeostasis in presymptomatic 3 × Tg-AD mice. J Neurosci 29:9458–9470
Chan SL, Mayne M, Holden CP, Geiger JD, Mattson MP (2000) Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons. J Biol Chem 275:18195–18200
Cheung K-H, Shineman D, Müller M, Cárdenas C, Mei L, Yang J, Tomita T, Iwatsubo T, M-Y LV, Foskett JK (2008) Mechanisms of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating. Neuron 58:871–883
Citri A, Malenka RM (2008) Synaptic plasticity: multiple forms, and mechanisms. Neuropsychopharmacology Rev 33:18–41
Dineley KT, Hogan D, Zhang WR, Taglialatela G (2007) Acute inhibition of calcineurin restores associative learning and memory in Tg2576 APP transgenic mice. Neurobiol Learn Mem 88:217–224
Dreses-Werringloer U, Lambert J-C, Vingtdeux V, Zhao H, Vais H, Siebert A et al (2008) A polymorphism in CALHM1 influences Ca2+ homeostasis, Aβ levels, and Alzheimer's disease risk. Cell 133:1149–1161
Foster TC, Sharrow KM, Masse JR, Norris CM, Kumar A (2001) Calcineurin links Ca2+ dysregulation with brain aging. J Neurosci 21:4066–4073
Geula C, Bu J, Nagykery N, Scinto LFM, Chan J, Joseph J, Parker R, Wu C-K (2003) Loss of calbindin-D28K from aging human cholinergic basal forebrain: relation to neuronal loss. J Comp Neurol 455:249–259
Green KN, Demuro A, Akbari Y, Hitt BD, Smith IF, Parker I, LeFerla FM (2008) SERCA pump activity is physiologically regulated by presenilin and regulates amyloid β production. J Cell Biol 181:1107–1116
Green KN, LaFerla FM (2008) Linking calcium to Aβ and Alzheimer's disease. Neuron 59:190194
Guo Q, Furukawa K, Sopher BL, Pham DG, Xie J, Robinson N, Martin GM, Mattson MP (1996) Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid betapeptide. NeuroReport 8:379–383
Guo Q, Christakos S, Robinson N, Mattson MP (1998) Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: reduced oxidative stress and preserved mitochondrial function. Proc Natl Acad Sci 95:3227–3232
Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide. Nat Rev Mol Cell Biol 8:101–112
Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353–356
Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, Malinow R (2006) AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52:831–843
Ichimiya Y, Emson PC, Mountjoy CQ, Lawson DE, Heizmann CW (1988) Loss of calbindin-28 K immunoreactive neurones from the cortex in Alzheimer-type dementia. Brain Res 475:156–159
Jacobsen JS, Wu C-C, Redwine JM, Comery TA, Arias R, Bowlby M et al (2006) Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci 103:5161–5166
Jiang Q, Lee CYD, Mandrekar S, Wilkinson B et al (2008) ApoE promotes the proteolytic degradation of A β. Neuron 58:681–693
Kasri NN, Kocks SL, Verbert L, Hébert SS, Callewaert G, Parys JB, Missiaen L, De Smedt H (2006) Up-regulation of inositol 1, 4, 5-trisphosphate receptor type 1 is responsible for a decreased endoplasmic-reticulum Ca2+ content of presenilin double knock-out cells. Cell Calcium 40:41–51
Khachaturian ZS (1989) Calcium, membranes, aging, and Alzheimer's disease. Introduction and overview. Ann N Y Acad Sci 568:1–4
Klyubin I, Walsh DM, Lemere CA, Cullen WK, Shankar GM, Betts V, Spooner ET, Jiang L, Anwyl R, Selkoe DJ, Rowan MJ (2005) Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo. Nat Med 11:556–561
Kuchibhotla KV, Goldman ST, Lattarulo CR, Wu H-Y, Hyman BT, Bacskai BJ (2008) Aβ plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 59:214–225
LaFerla FM (2002) Calcium dyshomeostasis and intracellular signaling in Alzheimer's disease. Nat Rev Neurosci 3:862–872
Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM (2009) Cellular prion protein mediates impairement of synaptic plasticity by amyloid-β oligomers. Nature 457:1128–1132
Leissring MA, Murphy MP, Mead TR, Akbari Y, Sugarman MC et al (2002) A physiological signalling role for the γ-secretase-derived intracellular fragment of APP. Proc Natl Acad Sci 99:4697–4702
Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH (2006) A specific amyloidbeta protein assembly in the brain impairs memory. Nature 440:352–357
Lopez JR, Lyckman A, Oddo S, LaFerla FM, Querfurth HW, Shtifman A (2008) Increased intraneuronal resting [Ca2+] in adult Alzheimer's disease mice. J Neurochem 105:262–271
Mattson MP (2004) Pathways towards and away from Alzheimer's disease. Nature 430:631–639
Nikolaev A, McLaughlin T, O’Leary DDM, Tessier-Lavigne M (2009) APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 457:981–989
Nixon RA (2007) Autophagy, amyloidogenesis and Alzheimer's disease. J Cell Sci 120:4081–4091
Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39:409–421
Offe K, Dodson SE, Shoemaker JT, Fritz JJ, Gearing M, Levey AI, Lah JJ (2006) The lipoprotein receptor LR11 regulates amyloid β production and amyloid precursor protein traffic in endosomal compartments. J Neurosci 26:1596–1603
Palop JJ, Jones B, Kekonius L, Chin J, Yu G-Q, Raber L, Masliah E, Mucke L (2003) Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits. Proc Natl Acad Sci 100:9572–9577
Pierrot N, Ghisdal P, Caumont AS, Octave JN (2004) Intraneuronal amyloid-beta1–42 production triggered by sustained increase of cytosolic calcium concentration induces neuronal death. J Neurochem 88:1140–1150
Pierrot N, Santos SF, Feyt C, Morel M, Brion JP, Octave JN (2006) Calcium-mediated transient phosphorylation of tau and amyloid precursor protein followed by intraneuronal amyloid-beta accumulation. J Biol Chem 281:39907–39914
Querfurth HW, Selkoe DJ (1994) Calcium ionophore increases amyloid beta peptide production by cultured cells. Biochemistry 33:4550–4561
Rogaeva E et al (2007) The neuronal sortilin-related receptor SoRL1 is genetically associated with Alzheimer disease. Nature Genet 39:168–177
Rohn TT, Vyas V, Hernandez-Estrada T, Nichol KE, Christie L-A, Head E (2008) Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the anti-apoptotic protein Bcl-2. J Neurosci 28:3051–3059
Rong YP, Distelhorst CW (2008) Bcl-2 protein family: versatile regulators of calcium signaling in cell survival and apoptosis. Ann Rev Physiol 70:73–91
Sanz-Blesco S, Valero RA, Rodriguez-Crespo I, Villalobos C, Núñez L (2008) Mitochondrial Ca2+ overload underlies Aβ oligomers neurotoxicity providing an unexpected mechanism of neuroprotection by NSAIDs. PloS One 3:e2718
Shirwany NA, Payette D, Xie J, Guo Q (2007) The amyloid beta ion channel hypothesis of Alzheimer's disease. Neuropsychiatric Dis Treatment 3:597–612
Smith IF, Hitt B, Green KN, Oddo S, LaFerla FM (2005) Enhanced caffeine-induced Ca2+ release in the 3 × Tg-AD mouse model of Alzheimer's disease. J Neurochem 94:1711–1718
Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, Salter MW, Lombroso PJ, Gouras GK, Greengard P (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 8:1051–1058
Stutzmann GE, Smith I, Caccamo A, Oddo S, LaFerla FM, Parker I (2006) Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult and aged Alzhemier’s disease mice. J. Neurosci 26:5180–5189
Stutzmann GE (2007) The pathogenesis of Alzheimer's disease- is it a lifelong “calciumopathy”. Neuroscientist 13:546–559
Supnet C, Grant J, Kong H, Westaway D, Mayne M (2006) Abeta 1–42 increases ryanodine receptor-3 expression and function in TgCRND8 mice. J Biol Chem 281:38440–38447
Thibault O, Gant JC, Landfield PW (2007) Expansion of the calcium hypothesis of brain ageing and Alzheimer's disease: minding the store. Ageing Cell 6:307–317
Townsend M, Shankar GM, Mehta T, Walsh DM, Selkoe DJ (2006) Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers. J Physiol. 572:477–492
Tu H, Nelson O, Bezprozvanny A, Wang Z, Lee SF, Hao YH, Serneels L, de Strooper B, Yu G, Bezprozvanny I (2006) Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell 126:981–993
Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535–539
Westerman MA, Cooper-Blacketer D, Mariash A, Kotilinek L, Kawarabayashi T, Younkin LH, Carlson GA, Younkin SG, Ashe KH (2002) The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci 22:1858–1867
Zhang C, Wu B, Beglopoulos V, Wines-Samuelson M, Zhang D, Dragatsis I, Südhof TC, Shen J (2009) Presenilins are essential for regulating neurotransmitter release. Nature 460:632–636
Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML et al (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat Gen. doi:10.1038/ng.440
Lambert J-C, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O et al (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat Gen. doi:10.1038/ng.439
Note added in proof
Two very recent reports have identified new AD susceptibility genes (CLU, CR1 and PICALM) [57, 58], which provide further support for the hypotheses outlined in this review. CLU encodes the protein clustrin, which function like ApoE (see Fig. 2) to bind soluble amyloids to regulate their toxicity [57, 58]. CR1 is the gene for the complement component (3b/4b) receptor 1, which functions in the complement system to clear soluble amyloids [58]. PICALM encodes a phosphatidylinositol-binding clathrin assembly protein, which is located in pre- and post-synaptic neuronal endings where it plays a role in clathrin-mediated endocytosis [57]. The genetic modifications to PICALM may function to divert APP to the late endosomes to promote the formation of soluble amyloids (see step 4 in Figure 2). In addition, mutated PICALM may contribute to the decline in synaptic plasticity seen in AD by increasing the rate of endocytosis. Such an action would thus mirror the effect of elevated Ca2+ by enhancing the process of long-term depression (LTD), which might be one of the major defects responsible for early memory loss in AD.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Berridge, M.J. Calcium hypothesis of Alzheimer’s disease. Pflugers Arch - Eur J Physiol 459, 441–449 (2010). https://doi.org/10.1007/s00424-009-0736-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00424-009-0736-1